MindMed Psychedelic Medicines Pipeline 2020

Loading viewer...

investor_presentation

Format: PDF investor_presentation

MindMed presents its diversified pipeline of psychedelic-inspired medicines in clinical development and research, including LSD-assisted therapy, 18-MC, and programs targeting opioid withdrawal, anxiety, and ADHD. The company outlines its clinical trial progress across multiple phases and R&D initiatives spanning LSD, MDMA, DMT, and psilocybin compounds.

Browse all investor_presentations →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from Mind Medicine MindMed

View all →

MindMed Corporate Presentation August 2024

investor_presentation

47 Pages

Mind Medicine (MindMed) 2020 Corporate Presentation Psychedelic Medicines

investor_presentation

Similar investor_presentations from other companies

Browse all →

Tonix Pharmaceuticals Holding Investor Presentation — September 2021

investor_presentation

29 Pages

Tonix Pharmaceuticals Holding Corp.

Odyssey Marine Exploration 2022 Corporate Investor Presentation

investor_presentation